Corsair Gaming Inc vs Immunovant Inc. Common Stock — how do they compare? Corsair Gaming Inc trades at $13.64 (market cap $1.42B), while Immunovant Inc. Common Stock trades at $30.5 (market cap $6.25B). The key difference: Immunovant Inc. Common Stock is far larger — about 4.4× Corsair Gaming Inc's market cap, and Corsair Gaming Inc is trading nearer its 52-week high, Immunovant Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Corsair Gaming Inc for 25 Days and Immunovant Inc. Common Stock for 1 Days on average.
| CRSR | IMVT | |
|---|---|---|
Market Cap | $1.42B | $6.25B |
Volume | 1,160,938 | 1,755,411 |
Sector | Technology | Health |
52-Week High | $14.35 | $44.96 |
52-Week Low | $4.58 | $17.03 |
Typical Hold Time | 25 Days | 1 Days |
Enterprise Value | $1.41B | $5.35B |
Signals from Pluang's Aura AI — not financial advice
Corsair Gaming (CRSR) trades at $13.63, up 0.29% with a bullish technical signal. The company has beaten earnings estimates for three consecutive quarters, with Q2 2026 EPS of $0.23 exceeding expectations by 228%. Recent product launches like the VOXARA microphone and strategic acquisitions demonstrate growth initiatives. Financials show improving cash flow trends with projected 2026 operating cash flow of $106 million, though net income margins remain thin at 2.53%.
CRSR presents a mixed outlook with strong earnings momentum and product innovation offset by valuation concerns at 42x P/E. Analyst consensus is cautious with 64% hold ratings and $12.40 price target below current levels. Key risks include competitive gaming peripherals market and execution of growth strategy. The stock's near-term direction hinges on Q3 earnings delivery and sustained margin improvement.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue generating segment
Read more on CRSR →Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →